D-1367-2020 Class III Terminated
FDA drug recall D-1367-2020 was initiated by Rising Pharmaceuticals, Inc. on Nov 15, 2019 and is designated Class III. Reason for recall: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside… The recall status is terminated (terminated Aug 22, 2022).
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2020
- Initiation Date
- Nov 15, 2019
- Termination Date
- Aug 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05
Reason for recall
Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
Distribution pattern
U.S.A. Nationwide
Code information
Lot # 089A016, Exp 12/31/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1367-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026